Karyopharm Therapeutics Inc.’s Post

At the American Society of Hematology (ASH) Annual Meeting this weekend, we are pleased to share new data on our gene-edited therapy. Learn more: https://lnkd.in/ej2E6QWb

Outline your day at #ASH24 with Hematology Daily News by your side! Catch our first issue today ➙ https://lnkd.in/gCftGFmA

Mark your calendars for a live webinar hosted by Fortis Institute of Blood Disorder on Innovations in Hematology. Join us on May 17th, 2024, from 7 PM to 8 PM and gain invaluable knowledge from leading specialists Dr. Jayastu Senapati and Dr. Nikhil M Kumar. Discover new technologies and innovative practices that are shaping the future of hematology. #AtFortisWeCare #FortisHealthcare #Webinar

📢All 12 manuscripts in the #SpecialIssue “#Hematologic #Malignancies: Challenges from Diagnosis to Treatment”, led by Dr. Ioanna Sakellari and Dr. Eleni Gavriilaki, Hematology Department and Dr. Eleni Gavriilaki, have been published! 🎉🎉 📌You are welcome to read via the following link: https://lnkd.in/dyADYnGy

At #ASH24, Hammad Tashkandi, MD discussed the clinical relevance in classification methods and the prognostic implications of subgrouping within TP53-mutated myelodysplastic neoplasms as outlined by WHO and ICC. Read more: https://lnkd.in/e_SzcJXH American Society of Hematology #MoffittASH24

How can your laboratory help reduce unnecessary complications for newly diagnosed Multiple Myeloma patients? Find out how from Prof. Guy Pratt who discusses how your laboratory can help guide blood test requesting and appropriate hematology referral. Download our case studies from hospitals in the United Kingdom, United States and Spain by here: https://hubs.li/Q02phTNn0

New publication 📝 Results from a post hoc analysis of the VIALE-A and VIALE-C trials published in American Journal of Hematology show that patients who received post-remission G-CSF had shorter delays between treatment cycles. Learn more: https://loom.ly/BB5nH3Q #leusm #MedNews #MedEd

New publication 📝 A review published in Clinical Hematology International summarized the impact of cGvHD, including the complications of long-term immunosuppression. Learn more: https://loom.ly/scYPRkM #GvHD #MedNews #MedEd

#Congress | 🔎 What subjects were amplified by #HCPs through social media during #EHA2024? In June, took place the European Hematology Association (EHA) 2024 Hybrid Congress. The following pages provide a brief overview of the volume of conversations, the share of voice of clinical trials most discussed, or top hashtags. Moreover, discover a focus on #multiplemyeloma with the topics of discussions. Access the SML EHA2024 full report by clicking this link 👉 https://lnkd.in/e6-MYzHj

[For US HCPs]: At this year’s American Society of Hematology Annual Meeting, we’re showcasing new data for patients with relapsed/refractory multiple myeloma in an oral presentation, as well as updates from across our hematology portfolio. Learn more about our R&D efforts: https://bit.ly/49odf5O #ASH24